TY - JOUR
T1 - Long-COVID postural tachycardia syndrome
T2 - an American Autonomic Society statement
AU - the American Autonomic Society
AU - Raj, Satish R.
AU - Arnold, Amy C.
AU - Barboi, Alexandru
AU - Claydon, Victoria E.
AU - Limberg, Jacqueline K.
AU - Lucci, Vera Ellen M.
AU - Numan, Mohammed
AU - Peltier, Amanda
AU - Snapper, Howard
AU - Vernino, Steven
N1 - Funding Information:
This work was supported in part by the National Institutes of Health Grant UL1 TR000445 and R00 HL122507.
Funding Information:
SRR has grant support from the Canadian Institutes of Health Research (Ottawa, Canada) and Dysautonomia International (East Moriches, NY, USA). SRR is a consultant for Lundbeck LLC and Theravance Biopharma, and serves as DSMB chair for a phase 2 study run by Arena Pharmaceuticals. SRR has received compensation for editorial activities (Associate Editor) with Autonomic Neuroscience—Basic and Clinical. ACA: Consultant for National Vaccine Injury Compensation Program, U.S. Department of Health and Human Services; research grant from Dysautonomia International. AB: None. VEC: Research grants from the Heart and Stroke Foundation of Canada, Craig H Nielsen Foundation, and International Collaboration on Repair Discoveries. JKL: None. MN: None. VEML: None. AP: None. HS: None. SV: SV has received research support from Biohaven, Dysautonomia International, Genentech, Grifols, Rex Griswold Foundation, and Athena/Quest Diagnostics (through a licensing contract) and personal compensation for consulting for Catalyst, Sage and Alterity.
Funding Information:
Federal funding initiatives designed to support a deeper comprehensive understanding of POTS are needed, in addition to the intentional investment in research to understand Long-COVID POTS []. In addition to the National Institutes of Health initiative and the Medical Research Council in the United Kingdom, we advocate for similar increases in research funding from the National Health and Medical Research Council in Australia, the Canadian Institutes of Health Research in Canada, and other leading research agencies worldwide.
Publisher Copyright:
© 2021, Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2021/6
Y1 - 2021/6
N2 - COVID-19 is a global pandemic that has had a devastating effect on the health and economy of much of human civilization. While the acute impacts of COVID-19 were the initial focus of concern, it is becoming clear that in the wake of COVID-19, many patients are developing chronic symptoms that have been called Long-COVID. Some of the symptoms and signs include those of postural tachycardia syndrome (POTS). Understanding and managing long-COVID POTS will require a significant infusion of health care resources and a significant additional research investment. In this document from the American Autonomic Society, we outline the scope of the problem, and the resources and research needed to properly address the impact of Long-COVID POTS.
AB - COVID-19 is a global pandemic that has had a devastating effect on the health and economy of much of human civilization. While the acute impacts of COVID-19 were the initial focus of concern, it is becoming clear that in the wake of COVID-19, many patients are developing chronic symptoms that have been called Long-COVID. Some of the symptoms and signs include those of postural tachycardia syndrome (POTS). Understanding and managing long-COVID POTS will require a significant infusion of health care resources and a significant additional research investment. In this document from the American Autonomic Society, we outline the scope of the problem, and the resources and research needed to properly address the impact of Long-COVID POTS.
KW - COVID
KW - Long COVID
KW - Position statement
KW - Postural tachycardia syndrome
UR - http://www.scopus.com/inward/record.url?scp=85103183529&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85103183529&partnerID=8YFLogxK
U2 - 10.1007/s10286-021-00798-2
DO - 10.1007/s10286-021-00798-2
M3 - Review article
C2 - 33740207
AN - SCOPUS:85103183529
SN - 0959-9851
VL - 31
SP - 365
EP - 368
JO - Clinical Autonomic Research
JF - Clinical Autonomic Research
IS - 3
ER -